ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care..

加利福尼亚州ALISO VIEJO（商业新闻短讯）--神经血管创新领域的全球领导者、Terumo Corporation的全资子公司MicroVention，Inc.今天宣布正式更名为Terumo Neuro，立即生效。这一名称的改变标志着公司发展的新篇章，同时保持了其对神经血管护理领域开创性创新的创造和商业化的坚定承诺。。

Founded in 1997 and acquired by Terumo Corporation in 2006, MicroVention has been at the forefront of developing technologies that support neurovascular surgeons in preserving and restoring brain health. As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation..

MicroVention成立于1997年，于2006年被Terumo Corporation收购，在开发支持神经血管外科医生保护和恢复大脑健康的技术方面一直处于领先地位。作为Terumo Neuro，该公司将继续其创新传统，更加专注于推动有影响力的增长，并利用Terumo的全球资源和声誉。。

Carsten Schroeder, President and CEO of Terumo Neuro, commented on the rebranding: 'This transformation reflects our growth as a company and Terumo's confidence in our future. For eighteen years, we have maintained independent branding as MicroVention, and now, as Terumo Neuro, we’re combining the best of MicroVention with the full strength and support of the Terumo family.

Terumo Neuro总裁兼首席执行官卡斯滕·施罗德（CarstenSchroeder）对品牌更名发表了评论：“这一转变反映了我们作为一家公司的成长以及Terumo对我们未来的信心。十八年来，我们一直保持着作为MicroVention的独立品牌，现在，作为Terumo Neuro，我们将MicroVention的最佳功能与Terumo家族的全力支持相结合。

Our culture, speed of innovation, focus on game-changing technologies, and close collaboration with physicians will remain unchanged.'.

我们的文化、创新速度、专注于改变游戏规则的技术以及与医生的密切合作将保持不变。”。

He continued, 'What will evolve is a deeper partnership with Terumo, a new visual brand, and a more defined brand identity under our new name and slogan, ‘Terumo Neuro: Game-changing Impact.’ Our strategy is expanding beyond our core focus on hemorrhagic and ischemic stroke and access solutions to encompass the neurovascular patient care continuum.'.

他继续说，“未来的发展将是与新视觉品牌Terumo建立更深入的合作关系，并在我们的新名称和口号“Terumo Neuro：改变游戏规则的影响力”下建立更明确的品牌标识。”我们的战略正在扩展，超出了我们对出血性和缺血性中风的核心关注，并获得了包括神经血管患者护理连续体在内的解决方案。”。

As Terumo Neuro, the company will continue its close collaboration with leading physicians worldwide, translating clinical insights into technologies that enhance patient outcomes. Schroeder emphasized that the company’s DNA remains rooted in innovation for ischemic stroke, hemorrhagic stroke, and access, while expanding into broader areas of neurovascular care..

作为Terumo Neuro，该公司将继续与全球领先的医生密切合作，将临床见解转化为提高患者预后的技术。施罗德强调，该公司的DNA仍然植根于缺血性中风、出血性中风和通路的创新，同时扩展到更广泛的神经血管护理领域。。

About Terumo Neuro (Formerly MicroVention, Inc.)

We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations.

我们致力于创造和提供改变游戏规则的Impact™-创新，重新定义神经血管内治疗的可能性，以有意义地促进医生的实践和患者的预后。Terumo Neuro成立于1997年，名为MicroVention，于2006年被Terumo Corporation收购，提供30多种产品，用于治疗脑动脉瘤、缺血性中风、颈动脉疾病和神经血管畸形。

Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica. For more information on Terumo Neuro, please visit www.terumoneuro.com..

Terumo Neuro产品总部位于加利福尼亚州，通过直销组织和战略分销伙伴关系在70多个国家销售。制造工厂位于加利福尼亚州的Aliso Viejo和哥斯达黎加的圣何塞。有关Terumo Neuro的更多信息，请访问www.terumoneuro.com。。

About Terumo Corporation

关于Terumo Corporation

Terumo (TSE:4543) is a global leader in medical technology and has been committed to 'Contributing to Society through Healthcare' for one hundred years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions.

Terumo（东京证交所代码：4543）是全球医疗技术的领导者，100年来一直致力于“通过医疗保健为社会做出贡献”。。

The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice.

该公司最初是一家日本温度计制造商，此后一直支持医疗保健。现在，其广泛的业务组合包括血管介入和心脏外科解决方案、输血和细胞治疗技术，以及日常临床实践所必需的医疗产品。

Terumo will further strive to be of value to patients, medical professionals, and society at large..

Terumo将进一步努力为患者、医疗专业人员和整个社会创造价值。。